Value-based procurement (VBP) is a journey, not a sprint. It’s about putting the patient at the centre of quality affordable healthcare through changes in procurement practices for medical technologies. Patient outcomes drive value and sustainability, not just price. The bigger picture indicates that VBP will create system cost saving through benefitting patients, rather than trying to attain the reverse – a win-win outcome.
Transforming from our price-based sourcing model to a value-based approach requires the sharing of goals and collaborative effort from all stakeholders – doctors, patients, procurement professionals, MedTech professions.
In this AHJ interview William Downey, Customer Solutions Partner ANZ, Johnson & Johnson Medical talks about working with Dr John Rooney, Head of Orthopaedics, St Vincents Hospital, Sydney and Sarah Sweeney, Operational Transformation & Service Innovation Manager, St Vincents Hospital Network, Sydney, on how St Vincents Hospital Network, implemented Value Based Procurement by working with a MedTech supplier and for the ultimately benefit to the patient.
-
New Generative AI and machine learning frontier on unused patient care data
Drawing from GE’s 125-year legacy in healthcare, Amit Yadav, CEO GE HealthCare ANZ is leading efforts to integrate AI into medical imaging devices and optimise workflow efficiencies. He stresses the importance of leveraging the vast amount of untapped healthcare data, with an emphasis on automating manual processes to enhance productivity. Additionally, his focus extends to utilising AI for workflow optimisation and ensuring compliance with local regulations and standards to prioritise safety.
-
1 million Australians with undiagnosed thyroid disorders remain at risk of irreparable damage
The Australian Thyroid Foundation is a national not-for-profit organisation with charity status aimed at patients and the healthcare community. The ATF’s focus is to support and educate its member base and promote our Good Thyroid Health Messaging throughout the Australian Community.
Australian Thyroid Foundation, CEO Beverley Garside attending the breakfast gave her response to the Federal Budget and the Foundation’s pre-budget submission, which was not granted.
-
Taiwanese health and research delegation visit Paratus clinical trial site in Canberra
In late August 2025, a Taiwanese delegation comprising government officials from the Taiwanese FDA, various governmental groups, and physicians and researchers from across Taiwan, visited Paratus Clinical’s trial site in Canberra. Their objective was to explore both the differences and similarities between the clinical research ecosystems of Taiwan and Australia.
